These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8636266)

  • 21. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.
    Yano K; Saji M; Hidaka A; Moriya N; Okuno A; Kohn LD; Cutler GB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1162-8. PubMed ID: 7714085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
    Parma J; Duprez L; Van Sande J; Cochaux P; Gervy C; Mockel J; Dumont J; Vassart G
    Nature; 1993 Oct; 365(6447):649-51. PubMed ID: 8413627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and functional analysis of novel inactivating thyrotropin receptor mutations in patients with thyrotropin resistance.
    Tsunekawa K; Onigata K; Morimura T; Kasahara T; Nishiyama S; Kamoda T; Mori M; Morikawa A; Murakami M
    Thyroid; 2006 May; 16(5):471-9. PubMed ID: 16756469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
    Porcellini A; Ruggiano G; Pannain S; Ciullo I; Amabile G; Fenzi G; Avvedimento EV
    Oncogene; 1997 Aug; 15(7):781-9. PubMed ID: 9266964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive activation of the thyroid-stimulating hormone receptor (TSHR) by mutating Ile691 in the cytoplasmic tail segment.
    Liu Z; Fan F; Xiao X; Sun Y
    PLoS One; 2011 Jan; 6(1):e16335. PubMed ID: 21283701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
    Führer D; Wonerow P; Willgerodt H; Paschke R
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity.
    Ho SC; Van Sande J; Lefort A; Vassart G; Costagliola S
    Endocrinology; 2001 Jul; 142(7):2760-7. PubMed ID: 11415994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    J Biol Chem; 1992 Dec; 267(34):24153-6. PubMed ID: 1332945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism.
    Alberti L; Proverbio MC; Costagliola S; Romoli R; Boldrighini B; Vigone MC; Weber G; Chiumello G; Beck-Peccoz P; Persani L
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2549-55. PubMed ID: 12050212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning, sequencing and functional expression of porcine thyrotropin (TSH) receptor cDNA1).
    Igarashi M; Nagata A
    Clin Chem Lab Med; 2003 Jun; 41(6):796-803. PubMed ID: 12880144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas.
    Porcellini A; Ciullo I; Pannain S; Fenzi G; Avvedimento E
    Oncogene; 1995 Sep; 11(6):1089-93. PubMed ID: 7566968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of the intact thyrotropin receptor in a human thyroid carcinoma cell line.
    Namba H; Yamashita S; Usa T; Kimura H; Yokoyama N; Izumi M; Nagataki S
    Endocrinology; 1993 Feb; 132(2):839-45. PubMed ID: 8381075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland.
    Abramowicz MJ; Duprez L; Parma J; Vassart G; Heinrichs C
    J Clin Invest; 1997 Jun; 99(12):3018-24. PubMed ID: 9185526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH.
    Russo D; Betterle C; Arturi F; Chiefari E; Girelli ME; Filetti S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4238-42. PubMed ID: 11095460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism.
    Claus M; Maier J; Paschke R; Kujat C; Stumvoll M; Führer D
    Thyroid; 2005 Sep; 15(9):1089-94. PubMed ID: 16187920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism.
    Biebermann H; Schöneberg T; Hess C; Germak J; Gudermann T; Grüters A
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4429-33. PubMed ID: 11549687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
    Calebiro D; de Filippis T; Lucchi S; Covino C; Panigone S; Beck-Peccoz P; Dunlap D; Persani L
    Hum Mol Genet; 2005 Oct; 14(20):2991-3002. PubMed ID: 16135555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor.
    Yano K; Kohn LD; Saji M; Okuno A; Cutler GB
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2586-91. PubMed ID: 9253338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific activation of the thyrotropin receptor by trypsin.
    Van Sande J; Massart C; Costagliola S; Allgeier A; Cetani F; Vassart G; Dumont JE
    Mol Cell Endocrinol; 1996 May; 119(2):161-8. PubMed ID: 8807635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
    Paschke R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.